Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential

Objective: To assess the effect of FSH on sperm fertilization potential and sperm intracellular structure in men with oligoteratoasthenozoospermia and a proven low fertilization rate in IVF. Design: Prospective, randomized, partial crossover study. Setting: IVF Unit, Colds Campus, Rabin Medical Center, Petah Tikva, Israel. Patient(s): Forty normogonadotropic, normogonadal men with oligoteratoasthenozoospermia and at least one previous IVF attempt in which fertilization failed or the fertilization rate was <30%. Intervention(s): The men were randomly assigned to treatment with daily injections of 75 IU of FSH or 150 IU of FSH for at least 60 days before IVF treatment. A control group of men underwent an IVF cycle without treatment and then were randomly assigned to join group 1A or 1B for an additional IVF cycle with treatment. Main Outcome Measure(s): LH, FSH, and testosterone levels during FSH treatment, evaluation of ultra-morphologic changes in sperm by electron microscopy, and comparison of fertilization rates in the control and study groups. Result(s): After treatment with 75 IU or 150 IU of FSH, the mean fertilization rates were 19.7% and 20.5%, respectively, compared with a 5.8% fertilization rate in the study control cycles. Conclusion(s): Prolonged treatment with FSH results in a significant increase in fertilization rates. This effect revised and accepted maybe related to improvements in subcellular components of the sperm. (C) 1999 by American Society for Reproductive Medicine.